Delineating the autistic phenotype in children with neurofibromatosis type 1.
Autism
Autism Diagnostic Interview-Revised (ADI-R)
Autism Diagnostic Observation Schedule-Second Edition (ADOS-2)
Autistic behaviours
Neurofibromatosis type 1
Journal
Molecular autism
ISSN: 2040-2392
Titre abrégé: Mol Autism
Pays: England
ID NLM: 101534222
Informations de publication
Date de publication:
04 01 2022
04 01 2022
Historique:
received:
14
06
2021
accepted:
14
12
2021
entrez:
5
1
2022
pubmed:
6
1
2022
medline:
28
4
2022
Statut:
epublish
Résumé
Existing research has demonstrated elevated autistic behaviours in children with neurofibromatosis type 1 (NF1), but the autistic phenotype and its relationship to other neurodevelopmental manifestations of NF1 remains unclear. To address this gap, we performed detailed characterisation of autistic behaviours in children with NF1 and investigated their association with other common NF1 child characteristics. Participants were drawn from a larger cross-sectional study examining autism in children with NF1. The population analysed in this study scored above threshold on the Social Responsiveness Scale-Second Edition (T-score ≥ 60; 51% larger cohort) and completed the Autism Diagnostic Interview-Revised (ADI-R) and/or the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2). All participants underwent evaluation of their intellectual function, and behavioural data were collected via parent questionnaires. The study cohort comprised 68 children (3-15 years). Sixty-three per cent met the ADOS-2 'autism spectrum' cut-off, and 34% exceeded the more stringent threshold for 'autistic disorder' on the ADI-R. Social communication symptoms were common and wide-ranging, while restricted and repetitive behaviours (RRBs) were most commonly characterised by 'insistence on sameness' (IS) behaviours such as circumscribed interests and difficulties with minor changes. Autistic behaviours were weakly correlated with hyperactive/impulsive attention deficit hyperactivity disorder (ADHD) symptoms but not with inattentive ADHD or other behavioural characteristics. Language and verbal IQ were weakly related to social communication behaviours but not to RRBs. Lack of genetic validation of NF1, no clinical diagnosis of autism, and a retrospective assessment of autistic behaviours in early childhood. Findings provide strong support for elevated autistic behaviours in children with NF1. While these behaviours were relatively independent of other NF1 comorbidities, the importance of taking broader child characteristics into consideration when interpreting data from autism-specific measures in this population is highlighted. Social communication deficits appear similar to those observed in idiopathic autism and are coupled with a unique RRB profile comprising prominent IS behaviours. This autistic phenotype and its relationship to common NF1 comorbidities such as anxiety and executive dysfunction will be important to examine in future research. Current findings have important implications for the early identification of autism in NF1 and clinical management.
Sections du résumé
BACKGROUND
Existing research has demonstrated elevated autistic behaviours in children with neurofibromatosis type 1 (NF1), but the autistic phenotype and its relationship to other neurodevelopmental manifestations of NF1 remains unclear. To address this gap, we performed detailed characterisation of autistic behaviours in children with NF1 and investigated their association with other common NF1 child characteristics.
METHODS
Participants were drawn from a larger cross-sectional study examining autism in children with NF1. The population analysed in this study scored above threshold on the Social Responsiveness Scale-Second Edition (T-score ≥ 60; 51% larger cohort) and completed the Autism Diagnostic Interview-Revised (ADI-R) and/or the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2). All participants underwent evaluation of their intellectual function, and behavioural data were collected via parent questionnaires.
RESULTS
The study cohort comprised 68 children (3-15 years). Sixty-three per cent met the ADOS-2 'autism spectrum' cut-off, and 34% exceeded the more stringent threshold for 'autistic disorder' on the ADI-R. Social communication symptoms were common and wide-ranging, while restricted and repetitive behaviours (RRBs) were most commonly characterised by 'insistence on sameness' (IS) behaviours such as circumscribed interests and difficulties with minor changes. Autistic behaviours were weakly correlated with hyperactive/impulsive attention deficit hyperactivity disorder (ADHD) symptoms but not with inattentive ADHD or other behavioural characteristics. Language and verbal IQ were weakly related to social communication behaviours but not to RRBs.
LIMITATIONS
Lack of genetic validation of NF1, no clinical diagnosis of autism, and a retrospective assessment of autistic behaviours in early childhood.
CONCLUSIONS
Findings provide strong support for elevated autistic behaviours in children with NF1. While these behaviours were relatively independent of other NF1 comorbidities, the importance of taking broader child characteristics into consideration when interpreting data from autism-specific measures in this population is highlighted. Social communication deficits appear similar to those observed in idiopathic autism and are coupled with a unique RRB profile comprising prominent IS behaviours. This autistic phenotype and its relationship to common NF1 comorbidities such as anxiety and executive dysfunction will be important to examine in future research. Current findings have important implications for the early identification of autism in NF1 and clinical management.
Identifiants
pubmed: 34983638
doi: 10.1186/s13229-021-00481-3
pii: 10.1186/s13229-021-00481-3
pmc: PMC8729013
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Informations de copyright
© 2021. The Author(s).
Références
J Autism Dev Disord. 2015 Aug;45(8):2283-94
pubmed: 25737019
Am J Med Genet A. 2007 Oct 1;143A(19):2261-73
pubmed: 17726688
Genet Med. 2012 Dec;14(12):977-82
pubmed: 22878510
JAMA Pediatr. 2021 Dec 1;175(12):e213982
pubmed: 34661613
BMJ Open. 2019 Sep 26;9(9):e030601
pubmed: 31558455
Am J Med Genet A. 2010 Feb;152A(2):327-32
pubmed: 20082463
J Am Acad Child Adolesc Psychiatry. 2016 Dec;55(12):1054-1063.e3
pubmed: 27871640
CNS Neurol Disord Drug Targets. 2016;15(5):533-43
pubmed: 27071790
J Autism Dev Disord. 2012 Feb;42(2):294-300
pubmed: 21516433
Dev Med Child Neurol. 2013 Feb;55(2):139-45
pubmed: 23163236
Child Psychiatry Hum Dev. 2003 Fall;34(1):3-17
pubmed: 14518620
Lancet Neurol. 2016 Mar;15(3):279-91
pubmed: 26497771
Front Psychiatry. 2021 Jan 15;11:585700
pubmed: 33519543
Autism Res. 2020 May;13(5):821-827
pubmed: 32124539
Res Autism Spectr Disord. 2009 Oct;3(4):959-966
pubmed: 21475640
Dev Med Child Neurol. 2021 Feb;63(2):235-236
pubmed: 33118173
Front Psychiatry. 2016 Nov 29;7:188
pubmed: 27965598
Eur Child Adolesc Psychiatry. 2021 Jun;30(6):961-984
pubmed: 32666205
Neuropsychol Rev. 2018 Sep;28(3):317-340
pubmed: 30097761
Am J Hum Genet. 2014 May 1;94(5):677-94
pubmed: 24768552
Annu Rev Clin Psychol. 2015;11:53-70
pubmed: 25581244
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
N Am J Med Sci (Boston). 2013;5(3):157-161
pubmed: 24349628
J Hum Genet. 2016 Jan;61(1):33-9
pubmed: 26446362
Br J Psychiatry. 2021 Jan;218(1):20-27
pubmed: 32641181
J Autism Dev Disord. 2013 Jun;43(6):1287-97
pubmed: 23065116
Lancet Neurol. 2015 Nov;14(11):1109-20
pubmed: 25891009
Nat Rev Dis Primers. 2017 Feb 23;3:17004
pubmed: 28230061
Infant Behav Dev. 2016 Aug;44:189-98
pubmed: 27450099
Cochrane Database Syst Rev. 2018 Jul 24;7:CD009044
pubmed: 30075057
Mol Autism. 2016 Jan 19;7:7
pubmed: 26788284
Autism Res. 2015 Oct;8(5):583-92
pubmed: 25712123
Mol Autism. 2013 May 15;4(1):12
pubmed: 23675638
Dev Med Child Neurol. 2013 Feb;55(2):131-8
pubmed: 23163951
Prog Brain Res. 2018;241:1-36
pubmed: 30447752
Dev Med Child Neurol. 2021 Feb;63(2):132
pubmed: 32614454
J Neurodev Disord. 2016 Jul 26;8:26
pubmed: 27516813
Lancet. 2014 Mar 8;383(9920):896-910
pubmed: 24074734
J Autism Dev Disord. 2014 May;44(5):1168-82
pubmed: 24682652
Prog Brain Res. 2018;241:37-62
pubmed: 30447756
Front Neurosci. 2018 May 16;12:304
pubmed: 29867317
Pediatrics. 2015 Oct;136 Suppl 1:S60-81
pubmed: 26430170
Nat Neurosci. 2006 Oct;9(10):1218-20
pubmed: 17001340
J Autism Dev Disord. 2011 Mar;41(3):311-9
pubmed: 20617374
J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9
pubmed: 18645422
Am J Med Genet B Neuropsychiatr Genet. 2015 Jan;168B(1):72-80
pubmed: 25388972
Front Pediatr. 2014 Jun 20;2:58
pubmed: 24999470
Lancet. 2018 Aug 11;392(10146):508-520
pubmed: 30078460
MMWR Surveill Summ. 2018 Nov 16;65(13):1-23
pubmed: 30439868
J Autism Dev Disord. 2015 Jun;45(6):1649-57
pubmed: 25475362
J Child Psychol Psychiatry. 2013 Feb;54(2):216-24
pubmed: 22823182
Am J Hum Genet. 2020 May 7;106(5):587-595
pubmed: 32359473
J Autism Dev Disord. 2009 May;39(5):693-705
pubmed: 19082876
Child Neuropsychol. 2006 Aug;12(4-5):247-67
pubmed: 16911971
Eur Child Adolesc Psychiatry. 2013 Jun;22(6):329-40
pubmed: 23322184
Child Dev. 1997 Feb;68(1):58-68
pubmed: 9084125
Pediatrics. 2013 Dec;132(6):e1642-8
pubmed: 24190681
Neurology. 2021 Aug 17;97(7 Suppl 1):S91-S98
pubmed: 34230207
Dev Med Child Neurol. 2019 Feb;61(2):174-180
pubmed: 29873078
Autism Res. 2013 Feb;6(1):33-41
pubmed: 23258569
Child Neuropsychol. 2011;17(4):313-29
pubmed: 21347908
Neuropsychology. 2017 May;31(4):361-370
pubmed: 28318281
Dev Med Child Neurol. 2020 Jul;62(7):813-819
pubmed: 32181506
JAMA Psychiatry. 2016 Dec 1;73(12):1276-1284
pubmed: 27760236
J Child Psychol Psychiatry. 2015 May;56(5):577-85
pubmed: 25243378
J Med Genet. 2014 Jan;51(1):10-20
pubmed: 24101678
Prog Brain Res. 2018;241:159-192
pubmed: 30447754
Annu Rev Genomics Hum Genet. 2013;14:355-69
pubmed: 23875798
J Child Psychol Psychiatry. 2006 Jun;47(6):582-90
pubmed: 16712635
Int Rev Psychiatry. 2018 Feb;30(1):18-24
pubmed: 29498298
Dev Med Child Neurol. 2021 Feb;63(2):233-234
pubmed: 32815557
J Child Psychol Psychiatry. 2014 May;55(5):485-94
pubmed: 24313878
J Autism Dev Disord. 2014 Oct;44(10):2400-12
pubmed: 23143131
J Autism Dev Disord. 2018 Jul;48(7):2278-2285
pubmed: 29423604
Eur Child Adolesc Psychiatry. 2014 Feb;23(2):81-93
pubmed: 23719758
Am J Intellect Dev Disabil. 2009 Jan;114(1):23-41
pubmed: 19143460
Arch Neurol. 1988 May;45(5):575-8
pubmed: 3128965